Concepedia

Sandra Moraña‐Fernández

SM

Statistics

Publications

4

Citations

62

H-Index

4

Active since

2022

Affiliations

Center for Research in Molecular Medicine and Chronic Diseases(Current)

Centro de Investigación en Red en Enfermedades Cardiovasculares

Universidade de Santiago de Compostela

Servicio Gallego de Salud

Instituto de Salud Carlos III

Sandra Moraña‐Fernández is an author at Center for Research in Molecular Medicine and Chronic Diseases specializing in pharmacology, inflammation, and atrial fibrosis.

Publications per year

2022–2023

4

Publications

4

The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

Alana Aragón‐Herrera, Sandra Moraña‐Fernández, Manuel Otero-Santiago et al. · Biomedicine & Pharmacotherapy · 2023 · 27 citations · Full text

, , +17

Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

Alana Aragón‐Herrera, Marinela Couselo‐Seijas, Sandra Feijóo‐Bandín et al. · Scientific Reports · 2022 · 13 citations · Full text

, , +16

Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

Isabel Moscoso, María Cebro-Márquez, Álvaro Martínez-Gómez et al. · Cells · 2022 · 11 citations · Full text

, , +14

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

Alana Aragón‐Herrera, Manuel Otero-Santiago, Laura Anido‐Varela et al. · Frontiers in Pharmacology · 2022 · 11 citations · Full text

, , +17

1–4 of 4